Trends on polymer-and lipid-based nanostructures for parenteral drug delivery to tumors

E Ajorlou, AY Khosroushahi - Cancer chemotherapy and pharmacology, 2017 - Springer
Purpose The dawn of the state-of-the-art methods of cancer treatments, nano-based delivery
systems, has dispensed with the mainstream chemotherapy for being inadequate in yielding …

Trends on polymer-and lipid-based nanostructures for parenteral drug delivery to tumors.

E Ajorlou, AY Khosroushahi - Cancer Chemotherapy and …, 2016 - europepmc.org
Purpose The dawn of the state-of-the-art methods of cancer treatments, nano-based delivery
systems, has dispensed with the mainstream chemotherapy for being inadequate in yielding …

[引用][C] Trends on polymer-and lipid-based nanostructures for parenteral drug delivery to tumors

E Ajorlou, AY Khosroushahi - Cancer Chemotherapy and Pharmacology, 2016 - cir.nii.ac.jp
Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Trends on polymer-and lipid-based nanostructures for parenteral drug delivery to tumors

E Ajorlou, AY Khosroushahi - Cancer Chemotherapy and …, 2017 - search.proquest.com
Purpose The dawn of the state-of-the-art methods of cancer treatments, nano-based delivery
systems, has dispensed with the mainstream chemotherapy for being inadequate in yielding …

Trends on polymer-and lipid-based nanostructures for parenteral drug delivery to tumors

E Ajorlou, AY Khosroushahi - Cancer Chemotherapy and Pharmacology, 2016 - infona.pl
Purpose The dawn of the state-of-the-art methods of cancer treatments, nano-based delivery
systems, has dispensed with the mainstream chemotherapy for being inadequate in yielding …

Trends on polymer-and lipid-based nanostructures for parenteral drug delivery to tumors

E Ajorlou, AY Khosroushahi - Cancer chemotherapy and …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose The dawn of the state-of-the-art methods of cancer treatments, nano-based delivery
systems, has dispensed with the mainstream chemotherapy for being inadequate in yielding …